InterSystems Wins Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies

InterSystemsInterSystems Corporation, a global leader in software for connected care, has been awarded the Frost & Sullivan 2012 European Company of the Year Award in Integrated Connected Health Technologies. Frost & Sullivan cited InterSystems for both its product innovation and its ability to deliver excellent customer value. In particular Frost & Sullivan’s analysts praised the InterSystems HealthShare® strategic informatics platform, which it described as "a one-stop solution that enables users to capture, share and understand and act on all their data, both structured and unstructured".

InterSystems was benchmarked against its competitors in five key areas:

  • Degree of innovation with products and technologies
  • Leadership in customer value
  • Growth strategy excellence
  • Growth implementation excellence
  • Leadership in market penetration

"The importance of integrated, connected care cannot be overstated as a key requirement for the next generation of healthcare informatics. With the ability to continuously derive value from their information and make it actionable at the point of care, health organisations can achieve the breakthrough transformation they need to address the challenges of managing costs while improving the quality of care," said Dominick Bizzarro, Global Business Manager, InterSystems HealthShare.

InterSystems HealthShare is a strategic healthcare informatics platform for hospitals, integrated delivery networks, and regional and national health information exchanges.

It is built on the InterSystems Caché® database and InterSystems Ensemble® integration platform. InterSystems DeepSee provides embedded real-time business intelligence capabilities, and InterSystems iKnow provides the ability to discover concepts and relationships within unstructured data.

The judges highlighted InterSystems' successful nationwide projects in countries including Sweden, Denmark, the Netherlands, and Scotland. They also cited InterSystems' growing reputation as a creative technology partner focused on advancing its implementation technology and post-implementation support to ensure customers achieve and exceed the expected value.

"Frost & Sullivan believes that InterSystems’ business strategy is customer-focused, and this has helped it to provide technologies that are widely used in the healthcare space. Its applications embed interoperability, analytics and other key components, which help its customers gain a competitive edge. All of these factors help InterSystems emerge as the worthy recipient of the 2012 Frost & Sullivan Company of the Year Award in the European Integrated Connected Health Technologies Market," said Divyaa Ravishankar, Senior Research Analyst, Healthcare and Lifescience IT, Frost & Sullivan.

"This award is excellent recognition for the work we are doing in Europe," said Jonathan Selby, UK & Ireland Country Manager at InterSystems. "We are continuing to grow our footprint in the European market by delivering outstanding technical innovation, real value for our partners and customers, and a connected care strategy that is ultimately focused on improving patient outcomes."

Related news articles:

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

About InterSystems
InterSystems Corporation is a global leader in software for connected care, with headquarters in Cambridge, Massachusetts, and offices in 25 countries. InterSystems CACHÉ® is the world's most widely used database system in clinical applications. InterSystems Ensemble® is a platform for rapid integration and the development of connectable applications. InterSystems HealthShare™ is a strategic healthcare informatics platform for information exchange and analytics within a hospital network, and across a community, region or nation. InterSystems' products are used by thousands of hospitals and laboratories worldwide, including all of the top ten hospitals on the Honor Roll of America's Best Hospitals as rated by U.S. News and World Report.

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...